NBE-Therapeutics AG Alternatives & Competitors
12 companies similar to NBE-Therapeutics AG — Next generation antibody drug conjugates
Companies similar to NBE-Therapeutics AG
Pheon Therapeutics
Pheon is an Antibody-Drug Conjugate specialist developing next generation ADCs for a range...
London, United Kingdom
Pyxis Oncology
Charting a course to therapeutics for difficult-to-treat cancer.
Boston, United States
ADC Therapeutics
Innovating Science. Inspiring Hope.
Lausanne, Switzerland
ProfoundBio
An oncology biotherapeutics company
Woodinville, United State...
Rival Readout
Competing with NBE-Therapeutics AG? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Oxford BioTherapeutics
Redefining the cancer-immune synapse for novel immune checkpoint mechanisms
Oxford, United Kingdom
ImmunoGen
Focusing on core therapeutic areas such as immunology, oncology, neuroscience, eye care, a...
CatalYm GmbH
Developing innovative immunotherapies to transform cancer patients’ lives by engaging thei...
Germany
Elevation Oncology
We are focused on discovering and developing selective cancer therapies to treat patients...
Boston, United States
ONA Therapeutics
First-in-class ADCs tailored to attack advanced cancer
Barcelona, Spain
ImmunoBiochem Corporation
Improving patient outcomes through innovations in biological therapeutics
Toronto, Canada
NextPoint Therapeutics, Inc.
Launching a new world of precision therapeutics through its leading scientific work on th...
About NBE-Therapeutics AG
NBE-Therapeutics AG, founded in 2012 and headquartered in Switzerland, is pioneering the development of next-generation antibody drug conjugates (ADCs) with a particular focus on oncology treatments. Their slogan, “Next generation antibody drug conjugates,” encapsulates their mission to enhance cancer patient outcomes...
Development of Antibody-Drug Conjugates, Research and Development in Oncology, Clinical Trials for Cancer Treatments, Biopharmaceutical Innovation
Cancer Patients, Healthcare Providers, Oncologists, Medical Researchers
Oncology Treatments, Antibody Drug Conjugates, Solid Tumors, Immune Oncology, Cancer Therapies, Biotech, ADC Platform, Immunological Anti-Tumor Effect, Anthracycline Payload, Immune-Stimulatory Therapies, Targeted Medicines, Pharmaceutical Development, Cancer Patient Solutions, Innovative Technologies, Clinical Pipeline
B2B, B2D
Licensing, Performance Based, Project Based
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around NBE-Therapeutics AG: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at NBE-Therapeutics AG on 11 Mar 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
